M.D., Chief Medical Officer, Juno DX
Biography
Experienced R&D Executive with a demonstrated history of working in the biotechnology industry. Specialized expertise in circulating cell free DNA, epigenetics and oncology including assay, application and technology design and development. Lead development and innovation for worlds first cell free noninvasive prenatal test (NIPT). Earned Doctor of Medicine degree (MD) from the Universität Hamburg.
Talk
Clinical Dx Showcase:
Juno DX
Juno Diagnostics™ is a health company bringing prenatal health information to patients by combining accessibility, affordability, and transparency. Juno Hazel™, is a non-invasive prenatal screening test that utilizes a proprietary Sample Collection Kit and improves access to testing without the high cost and phlebotomy requirements.
Enabling accessible and affordable prenatal testing
Juno™ is a health company bringing prenatal health information to patients by combining accessibility, affordability, and transparency.
Session Abstract – PMWC 2023 Silicon Valley
Showcase Track S2 - January 25 9.00 A.M.-1.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-4.45 P.M.,Showcase Track S2 - January 27 9.00 A.M.-2.15 P.M.
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative
